Agile Therapeutics Inc Valor contable por acción
¿Qué es el Valor contable por acción de Agile Therapeutics Inc?
El Valor contable por acción de Agile Therapeutics Inc es -1.04
¿Cuál es la definición de Valor contable por acción?
El valor en libros por acción es el activo de una empresa menos el pasivo dividido por el número de acciones en circulación.
The book value of a company is the value of its assets according to its balance sheet account balance. For assets, the value is based on the original cost of the asset less any depreciation, amortization or impairment costs made against the asset. Traditionally, a company's book value is its total assets minus intangible assets and liabilities. However, in practice, depending on the source of the calculation, book value may variably include goodwill, intangible assets, or both. The value inherent in its workforce, part of the intellectual capital of a company, is always ignored. The book value of a company may be also referred as with the term net asset value.
The book value per share is the the balance sheet equity value divided by the number of shares outstanding at the date of the balance sheet. Book value per share can be used to generate a measure of comprehensive earnings, when the opening and closing values are reconciled. The sale of shares/units by a business increases the total book value. Book value per share will increase if the additional shares are issued at a price higher than the pre-existing book value per share. The purchase of its own shares by a business will decrease total book value. Book value per share will decrease if more is paid for them than was received when originally issued. Dividends paid out will decrease book value per share value.
Valor contable por acción de compañías en Sector Health Care en NASDAQ en comparadas con Agile Therapeutics Inc
¿Qué hace Agile Therapeutics Inc?
agile therapeutics is a forward-thinking women's healthcare company dedicated to fulfilling the unmet health needs of today's women. our product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. our lead product candidate, twirla®, (ethinyl estradiol and levonorgestrel transdermal system), also known as ag200-15, is a once-weekly prescription contraceptive patch that recently completed phase 3 trials. twirla is based on our proprietary transdermal patch technology, called skinfusion®, which is designed to provide advantages over currently available patches and is intended to optimize patch adhesion and patient wearability. for more information, please visit the company website at www.agiletherapeutics.com. connect with us on twitter at @agilether.
Empresas con valor contable por acción similar a Agile Therapeutics Inc
- Akerna Corp tiene Valor contable por acción de -1.07
- Predilife S.A tiene Valor contable por acción de -1.07
- Armata Pharmaceuticals Inc tiene Valor contable por acción de -1.06
- C & C Constructions tiene Valor contable por acción de -1.06
- C & C Constructions tiene Valor contable por acción de -1.06
- Xiana Mining tiene Valor contable por acción de -1.05
- Agile Therapeutics Inc tiene Valor contable por acción de -1.04
- Global Wellness Strategies tiene Valor contable por acción de -1.04
- Rochester Resources tiene Valor contable por acción de -1.03
- Les Hotels de Paris SA tiene Valor contable por acción de -1.03
- Uxin Ltd tiene Valor contable por acción de -1.03
- Opthea Ltd tiene Valor contable por acción de -1.02
- Trinseo PLC tiene Valor contable por acción de -1.02